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Abstract: 
Neonatal female and male rats were exposed to airborne manganese sulfate (MnSO4) during gestation and 
postnatal d 1–18. Three weeks post-exposure, rats were killed and we assessed biochemical end points indica-
tive of oxidative stress in five brain regions: cerebellum, hippocampus, hypothalamus, olfactory bulb, and 
striatum. Glutamine synthetase (GS) protein levels, metallothionein (MT) and GS mRNA levels, and total glu-
tathione (GSH) levels were determined for all five regions. Overall, there was a statistically significant effect of 
manganese exposure on decreasing brain GS protein levels (p=0.0061), although only the highest dose of man-
ganese (1 mg Mn/m
3
) caused a significant increase in GS messenger RNA (mRNA) in both the hypothalamus 
and olfactory bulb of male rats and a significant decrease in GS mRNA in the striatum of female rats. This high-
est dose of manganese had no effect on MT mRNA in either males or females; however, the lowest dose (0.05 
mg Mn/m
3
) decreased MT mRNA in the hippocampus, hypothalamus, and striatum in males. The median dose 
(0.5 mg Mn/m
3
) led to decreased MT mRNA in the hippocampus and hypothalamus of the males and olfactory 
bulb of the females. Overall, manganese exposure did not affect total GSH levels, a finding that is contrary to 
those in our previous studies. Only the cerebellum of manganese-exposed young male rats showed a significant 
reduction (p<0.05) in total GSH levels compared to control levels. These data reveal that alterations in 
biomarkers of oxidative stress resulting from in utero and neonatal exposures of airborne manganese remain 
despite 3 wk of recovery; however, it is important to note that the doses of manganese utilized represent levels 
that are 100- fold to a 1000-fold higher than the inhalation reference concentration set by the US Environmental 
Protection Agency. 
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Article: 
INTRODUCTION 
Recently, our group has reported the responses of several markers of oxidative stress resulting from manganese 
exposure in several rat models (1–3). These models include young male and female rats as well as senescent 
male rats exposed to manganese for periods of time ranging from 3 to 13 wk. The data reported herein explore 
the effects of in utero and neonatal manganese inhalation on oxidative stress markers in several rat brain 
regions. Manganese is an essential trace metal that is found in all tissues and is required for normal amino acid, 
lipid, protein, and carbohydrate metabolism (4). Although manganese deficiency is extremely rare in humans, 
toxicity resulting from overexposure to manganese is more prevalent and the brain appears to be especially 
vulnerable. Manganese neurotoxicity is most commonly associated with occupational exposure to aerosols or 
dusts that contain extremely high levels (> 1–5 mg Mn/m
3
) of manganese, consumption of contaminated well 
water, or parenteral nutrition therapy in patients with liver disease (5–8). 
 
Attention to airborne manganese has increased because of the use of the antiknock agent 
methylcyclopentadienyl manganese tricarbonyl (MMT) in some unleaded gasolines, although the level of 
manganese resulting from MMT in urban areas does not exceed tolerable levels set by the governments of 
Canada and the United States (9). It has been speculated that chronic low-level manganese exposure might play 
a role in the pathogenesis of neurodegenerative disorders, especially in susceptible populations. 
Oxidative stress has been implicated as a contributing mechanism by which manganese might be cytotoxic (10). 
The oxidation of dopamine by manganese is a potential mechanism by which manganese-induced oxidative 
stress could occur, especially because manganese accumulates in dopamine-rich brain regions of rodents and 
primates (e.g., basal ganglia) (11). Another possible mechanism is that manganese, through its sequestration in 
mitochondria, interferes with proper respiration, thereby leading to excessive production of reactive oxygen 
species. One laboratory reported inhibition of complex I of the electron transport chain after treatment of PC12 
cell cultures with MnCl2 (12). Another laboratory showed evidence suggesting that the ATPase complex is 
inhibited at very low levels of mitochondrial manganese and that complex I is inhibited only at higher 
manganese concentrations (13). It has been shown that trivalent manganese is more effective at inhibiting 
complex I (14–16), but the divalent form is, by far, the predominant species within cells and is largely bound to 
ATP (15,17). Nevertheless, in biological media, manganese of any valence will spontaneously give rise to 
infinitesimal amounts of trivalent manganese, and HaMai et al. (18) demonstrated that even at trace amounts, 
trivalent manganese can cause formation of reactive oxygen species. 
 
This present study extends the previous observations by examining the interactions of sex on the reversibility of 
altered end points of oxidative stress as a result of manganese exposure in select brain regions. The rats in the 
present study were exposed to levels of manganese similar as those in one of our earlier studies (1). Finally, the 
developmental time-point of the exposure is a novel aspect of this study, furthering the understanding of 
neurological consequences of manganese exposure. 
 
MATERIALS AND METHODS 
Experimental Design 
Adult (F0 male and female rats) CD rats (10 rats/ gender/ exposure concentration) were exposed to either air or 
MnSO4 (0.05, 0.5, or 1 mg Mn/m
3
) beginning 28 d prior to breeding and for up to 14 d during the mating 
period. Presumed pregnant female rats were exposed to either air or MnSO4 from gestation day (GD) 0 through 
GD 19. Inhalation exposures were not conducted when parturition was expected to occur (i.e., after GD 19). 
Lactating rats and their pups were then concurrently exposed to either air or MnSO4 beginning 1 d after 
parturition (day of parturition was designated as postnatal day [PND] 0) using methods described by Dorman et 
al. (19). Inhalation exposure continued from PND 1 through PND 18. Oxidative stress end points were 
determined in the remaining offspring (whenever possible, n = 1 rat/ sex/ exposure concentration/time-point) on 
PND 45 ± 1. 
 
Chemicals 
Manganese(II) sulfate monohydrate (MnSO4·H2O) (CAS Registry no. 10034-96-5) was obtained from Sigma-
Aldrich Chemical Company, Inc. (Milwaukee, WI). This relatively water-soluble material is a white to pale 
pink crystalline powder that contains 32.6% manganese. All other chemicals were purchased from Sigma 
Chemical (St. Louis, MO) unless otherwise noted and were of the highest possible quality. 
 
Animals 
The study was conducted under federal guidelines for the care and use of laboratory animals (National Research 
Council, 1996) and was approved by the CIIT Institutional Animal Care and Use Committee. Young (6 wk old) 
male (n=40) and female (n=40) CD rats were purchased from Charles River Laboratories, Inc. (Raleigh, NC). 
All prestudy health screens were negative. Animals were acclimated for approx 2 wk in a HEPA-filtered, mass 
air-displacement room maintained at 18.5–21.5°C and 40–60% relative humidity in CIIT’s AAALAC-
accredited animal facility. Rats were individually housed in suspended stainless-steel cages (Lab Products, Inc., 
Seaford, DE) with an automatic watering system that provided reverse osmosis purified water ad libitum. A 
pelleted, semipurified AIN-93G certified diet from Bio-Serv (Frenchtown, NJ) formulated to contain approx 10 
ppm manganese and 35 ppm iron was given ad libitum (except during inhalation exposures) throughout the 
study. Fluorescent lighting was kept on a 12-h light–dark cycle (0600–1800). A study day for these exposures 
was defined as a 6-h exposure, generally from 0830 to 1430. 
 
 
Breeding Procedures 
The parental generation was manganese exposed by inhalation 7 d per week, 6 h per day, prior to breeding (see 
next section for exposure details). The rats were mated after the daily exposure (female added to male’s cage) 
and separated in the morning for the next exposure day. Each pair was selected randomly within each exposure 
group for a period of up to 14 d, with no change in mating partner. Females were examined daily after each 
cohabitation period for a copulation plug or sperm-positive smear, which indicated successful mating, and was 
designated gestation day 0 (GD 0). 
 
Manganese Exposures 
Rats were exposed whole body in 8-m
3
 Hinners-style, stainless-steel and glass inhalation exposure chambers 
using exposure cage rack units. MnSO4 atmospheres were generated and characterized using methods described 
by Dorman et al. (19). Nominal MnSO4 exposure concentrations of 0.05, 0.5, and 1 mg Mn/m
3
 were used in this 
study. The target particle size distribution was 1.5–2 µm mass median aerodynamic diameter (MMAD) with a 
geometric standard deviation (GSD) < 2. Control groups were exposed to HEPA-filtered air only. The overall 
means (± SD) for the chamber concentrations based on daily optical particle sensor data were 0.001 ± 0.000, 
0.157 ± 0.011, 1.50 ± 0.10, and 3.03 ± 0.18 mg/m
3
 for the target exposure concentrations of 0, 0.15, 1.53, and 
3.10 mg MnSO4/m
3
, corresponding to 0, 0.05, 0.5, and 1 mg Mn/m
3
, respectively. The particle size distribution 
was 1.03 µm geometric mean diameter (GMD) and 1.52 GSD, 1.05 µm GMD (GSD = 1.53), and 1.07 µm 
GMD (GSD = 1.55) for the target concentrations of 0.150, 1.53, and 3.10 mg MnSO4/m
3
, respectively. 
 
Tissue Collection 
At the termination of exposures, euthanasia (with CO2) was carried out in accordance with NIH guidelines. The 
brain areas of interest were dissected out and weighed and then placed in high-purity linear polyethylene vials, 
frozen in liquid nitrogen, and stored at –80°C until analysis. 
 
RNA Isolation and Northern Blot Analysis 
The tissue samples were homogenized and total RNA was extracted with a monophase phenol and guanidine 
isothiocyanate solution (RNA STAT-60; Tel-Test, Inc., Friendswood, TX). For Northern blot analysis, 10 µg of 
RNA were electrophoresed on a 1.2% agarose denaturing gel and transferred onto a positively charged Nylon 
membrane (Nytran SuPerCharge; Schleicher & Schuell, Keene, NH) overnight by capillary transfer in 10X SSC 
(1X SSC = 0.15 M sodium chloride, 0.015 M sodium citrate) buffer. The RNA was immobilized with an 
ultraviolet (UV) crosslinker. 
 
For metallothionein (MT) or glutamine synthesase (GS), the blot was prehybridized in 50% deionized 
formamide, 5X Denhardt’s solution, 10% dextran sulfate, 0.1% sodium dodecyl sulfate (SDS), 4X SSC, 100 
g/mL denatured salmon sperm DNA, 20 mM Tris-HCl, pH 8.0 for 1 h at 45°C. To probe for MT or GS, the blot 
was prehybridized in Ultrasensitive Hybridization Buffer (Ambion, Inc., Austin, TX) at 45°C. The RNA blots 
were then hybridized overnight with 10
5
 cpm/mL of [α-
32
P]dCTP-labeled random primed cDNA probe (approx 
1 × 10
8
 cpm/µg; RadPrime DNA Labeling System; Gibco-BRL/Life Technologies, Rockville, MD). Mem-
branes were washed two to three times in 2X SSC/0.1% SDS at 45°C for 20 min and then exposed to Kodak 
Biomax MR Film at –80°C with intensifying screens for 24–36 h. The autoradiograms were quantified by 
densitometry scanning in conjunction with the TINA v2.09e computer program (Raytest USA, Inc., 
Wilmington, NC). To correct for total loaded RNA level, the blots were stripped in 0.1X SSC/0.1%SDS/40 mM 
Tris-HCl buffer and probed for 28s rRNA (20). 
 
Protein Isolation and Western Blot Analysis 
Tissue lysates were centrifuged for 10 min at 10,000g to remove cellular debris, and the protein content of the 
resultant supernatant was determined with the bicinchoninic acid method (Pierce Chemical, Rockford, IL). An 
aliquot of 100 µg of protein was concentrated from the imidazole lysis buffer by organic extraction. Sample 
volumes were brought up to 400 µL with water and an equal volume of methanol (400 µL) was added, followed 
by 100 µL of chloroform. Samples were vortexed for 20 s and centrifuged at 14,000g for 3 min. The upper layer 
was removed and discarded. 
An additional 300 µL of methanol was added to each sample and they were again vortexed and centrifuged. The 
supernatant was removed and the pellet was air-dried. Each pellet was then dissolved in 100 µL of 2% SDS and 
heated to 65°C. 
 
Five microliters of 5X loading buffer (50% glycerol; 10% SDS, 0.25 M TrisHCl, pH 6.8) and dithiothreitol 
(DTT) (final concentration 100 mM) were added to the extracted proteins and the samples were boiled for 10 
min. Bromophenol blue (1 µL of a 50% [w/v] solution) was added and proteins were resolved by denaturing 
sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) with a 5% stacking and 8% resolving 
acrylamide gels in a 0.1% SDS, 25 mM Tris-HCl, 192 mM glycine buffer. Following fractionation, proteins 
were electrophoretically transferred to a nitrocellulose membrane (Protran, BA83; Schleicher & Schuell, Keene, 
NH) in 20% methanol, 0.1% SDS, 25 mM Tris-HCl, and 192 mM glycine for 3 h at 60 V. 
 
Membranes were blocked with 5% low-fat powdered milk in Trisbuffered saline with Tween (TBST, 0.1% 
Tween, 150 mM NaCl, 20 mM TrisHCl) containing 0.1% gelatin (type B from bovine skin; Sigma, St. Louis, 
MO). GS proteins were detected with a monoclonal antibody (Chemicon, Temecula, CA) diluted to 1 : 2000 
followed by incubation with a horseradish peroxidase-conjugated goat anti-mouse secondary antibody diluted to 
1 : 2000 (Kirkegaard and Perry Laboratories, Gaithersburg, MD), both in TBST and 5% milk for 1 h. Protein 
bands were visualized with the Renaissance enhanced chemiluminescence system (New England Nuclear, 
Boston, MA). The autoradiograms were quantified by densitometry scanning in conjunction with the TINA 
v2.09e computer program (Raytest USA, Inc., Wilmington, NC). 
 
GSH Level Determination 
Tissue samples (50–100 mg) were homogenized in 1 mL of 10% (v/v) perchloric acid containing 1 mM 
bathophenanthroline disulfonic acid (BPDS) and L-γ-glutamyl-L-glutamate. The mixture was vortexed and cen-
trifuged, and an aliquot was removed for high-performance liquid chromatography (HPLC) analysis (21) with a 
Waters model 600E multisolvent delivery system using an ion-exchange method with a methanol-acetate 
mobile phase and gradient elution. The limit of GSH detection was approx 50 pmol, which equated to approx 
0.4 nmol/mg protein (22,23). 
 
Statistical Analysis 
The data were analyzed using the SAS system v8.2 (SAS Institute, Cary, NC). Data were examined for 
normality of distribution and presence of outliers. Analysis of variance with repeated-measures factors (brain 
regions) and between-groups factors was used to test for interactions between manganese exposure and sex. 
When the overall significance resulted in rejection of the null hypothesis (p < 0.05), the Tukey’s HSD post-hoc 
test was used to evaluate mean differences. 
 
RESULTS 
GS Protein and mRNA 
Although manganese exposure had an overall effect on significantly decreasing GS protein in both male and 
female rats (p=0.0061) (Table 1), GS mRNA levels were affected more selectively (Table 2). For example, GS 
mRNA levels significantly decreased in the olfactory bulb (lowest and median dose) (p=0.004) and striatum (all 
three doses) of manganese-exposed F1 female rats (p=0.012), but these two brain regions were unaffected in F1 
male rats (Table 2). 
 
MT mRNA 
The MT mRNA levels were significantly decreased in the hippocampus and hypothalamus of F1 males that 
were exposed to the lowest and median doses of manganese (p<0.05), but those exposed to the highest dose of 
manganese displayed unchanged MT mRNA in these two regions (Table 3). The F1 female rats exposed to 
manganese were unaffected in terms of MT mRNA levels except in the striatum, where there was a significant 
decrease in mRNA levels across all exposure doses (p=0.002) (Table 3). 
 
GSH 
All three manganese treatments significantly decreased GSH levels in the olfactory bulb of F1 female rats 
(p=0.047) but not in the male rats (Table 4). Conversely, all three manganese treatments significantly decreased 
GSH levels in the cerebellum of the F1 male rats (p=0.018) but not in their female littermates (Table 4). 
 
DISCUSSION 
The current inhalation reference concentration (RfC) for manganese, as set by the US Environmental Protection 
Agency, is 0.05 µg Mn/m
3
 (24). Thus, the concentrations of manganese used in this study were 1000, 10,000, 
and 20,000 times this standard for the lowest, median, and highest doses, respectively. Manganese 
concentrations in the olfactory bulb, striatum, and cerebellum of rats that were exposed similarly to manganese 
sulfate have been reported (25). Dorman and co-workers (26) observed increased brain manganese 
concentrations in PND 14 and PND 19 pups that were exposed to manganese sulfate at > 0.05 mg Mn/m
3
. 
Increased striatal, olfactory bulb, and cerebellum concentrations were approx twofold to threefold higher than 
those observed in controls. Adult (F1) rats that were exposed as neonates to MnSO4 had returned to control 
brain manganese concentrations when assessed at PND 45 ± 1 (26). When a similar paradigm of manganese 
exposure followed by a recovery period was administered to older rats, manganese concentrations in some brain 
regions, in particular the olfactory bulb, remained elevated when compared to air-exposed rats (19). However, 
in the present study, younger rats that were exposed to manganese sulfate in utero and during lactation fully 
normalized their brain regional manganese concentrations by PND 45 (i.e., 3 wk after exposure sessions ended). 
It is likely that this ability to normalize brain manganese concentrations reflects the increased requirements of 
the developing rat brain (27). 
 
This study presents novel data that show alterations in oxidative stress markers in specific brain regions of 
developing male and female rats after 3 wk of recovery from in utero and neonatal exposures to airborne 
manganese. Furthermore, these changes in brain regional oxidative stress markers occurred in the absence of 
increased brain manganese concentrations and were in contrast to our earlier studies conducted in adult rats (1–
3). 
 
One can detect the presence of oxidants by measuring species that are known to increase or decrease in response 
to oxidative stress. This includes ubiquitous antioxidants, such as GSH, as well as biomarkers that are more 
specific to particular tissue types (e.g., glutamine synthetase). In the central nervous system, GS is localized 
exclusively in astrocytes (28), where it has a critical role in amino acid metabolism. Glutamine synthetase 
metabolizes glutamate that is removed by astrocytes from the extracellular space to glutamine, and the latter is 
recycled to neurons as part of the glutamate–glutamine cycle (29). Glutamine synthetase is highly susceptible to 
oxidation and subsequent rapid degradation and, therefore, it serves as an excellent marker for the presence of 
reactive oxygen species in the brain (30). 
 
Although GS protein levels decreased in most brain regions of manganese exposed male and female rats, only 
the cerebellum in the male rats exposed to the median dose had a statistically relevant decrease in GS protein 
levels compared to nonexposed rats (Table 1) and this decrease occurred despite normal manganese 
concentrations in this brain region. This is in contrast to our previous studies in which the effects of manganese 
exposure in older animals of both sexes were more selectively affected [e.g., hippocampus only in male rats and 
hypothalamus in female rats (3)]. Corroborating earlier findings (1–3), the GS mRNA levels (Table 2) measured 
in this study was not reflected in altered amounts of GS protein (i.e., brain regions that had increased mRNA 
levels did not have increased protein levels). In fact, there were more statistically significant changes in GS 
mRNA than there were in the protein levels, which is in contrast to our prior studies (1–3). There were 
significant increases in GS mRNA levels in the hypothalamus and olfactory bulb of male rats recovering from 
the highest manganese exposure, whereas GS mRNA levels were significantly decreased in the striatum of 
female rats recovering from the median and high exposures (Table 2). Sex differences in the response to 
manganese exposure were exemplified in the striatum, where the females had significant decreases in GS 
mRNA but the males were unaffected in this brain region. 
 
The MTs are a class of highly conserved proteins known to bind metals, but in recent years, evidence has shown 
that they might also have some important antioxidant properties (31). In vitro experiments demonstrated that 
MTs had a greater ability at scavenging oxygen radicals when compared with other sulfhydryl-containing 
molecules (32) and they increased more than glutathione (GSH), Mn-SOD (superoxide dismutase) catalase, and 
other well-known antioxidants (33). We found that MT mRNA levels were significantly decreased in the 
hippocampus, hypothalamus, and striatum in males recovering from the lowest manganese dose and in the 
hippocampus and hypothalamus in those recovering from the median dose manganese exposure (Table 3). The 
only statistically relevant change in the females was in the olfactory bulb of female rats recovering from the 
median dose (Table 3). 
 
Glutathione is a ubiquitous antioxidant formed from three amino acids, glutamate, cysteine, and glycine (γ-
glutamylcysteinylglycine). It constitutes approx 90% of the intracellular nonprotein thiols (34) and functions in 
conjugation and elimination of toxic molecules, thereby maintaining cellular redox homeostasis (34). We 
previously reported that GSH levels were significantly lowered in the striatum of female and old male rats upon 
manganese exposure (3) and that this effect was absent in the young male rats, which was consistent with our 
other study (1). These data are consistent with the findings of a previous study that showed decreased GSH 
levels in the striatum of aged rats exposed to manganese chloride (35). In this current study, the only 
statistically significant effect of manganese exposure appeared in the cerebellum of male rats recovering from 
the highest manganese exposure level (Table 4). This relative lack of an effect of manganese exposure on GSH 
in these animals likely reflects the reversibility of manganese exposure and/or the plasticity of the developing 
nervous system in terms of GSH metabolism. Although this is speculative, it is consistent with the critical role 
GSH plays in the maintenance of redox homeostasis. 
 
In conclusion, we report for the first time the consequences of in utero and early developmental airborne 
manganese exposure on end points of oxidative stress in developing female and male rats. These alterations are 
not associated with increased manganese as in our prior studies, but these changes persist even after brain 
regional manganese concentrations return to control levels. Furthermore, the reversibility of these alterations in 
markers of oxidative stress caused by manganese exposure is influenced by the sex of the rat. Unlike our 
previous studies (1–3), manganese exposure in young male rats had more of an impact on oxidative stress end 
points than it did in female rats. We cannot determine whether this difference is the result of a lack of 
reversibility in the male rats or whether markers of oxidative stress in the female rat are less affected by 
manganese exposure. It is noteworthy that these effects occurred at doses of manganese 10–20 thousand times 
higher than the current RfC. We are presently undertaking a study in which we will specifically examine some 
of these reversibility issues. 
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